Autor: "Barcenas CH" - OpacWWW

Skocz do pozycji: 1.

Informacja:: Dostęp do tej pozycji wymaga zalogowania się.

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 2.

Informacja:: Dostęp do tej pozycji wymaga zalogowania się.

Czasopismo naukowe

na półce

Szczegóły

Skocz do pozycji: 3.

Tytuł:: The Impact of Treatment for Smoking on Breast Cancer Patients' Survival.
Autorzy:: Singareeka Raghavendra A; Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
Kypriotakis G; Department of Behavioral Science, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
Karam-Hage M; Department of Behavioral Science, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.; Department of Psychiatry, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
Kim S; Department of Behavioral Science, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
Jizzini M; Department of Medicine, State University of New York at Buffalo, Buffalo, NY 14260, USA.
Seoudy KS; Department of Psychiatry and Neurobehavioral Sciences, University of Virginia, Charlottesville, VA 22901, USA.
Robinson JD; Department of Behavioral Science, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
Barcenas CH; Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
Cinciripini PM; Department of Behavioral Science, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
Tripathy D; Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
Ibrahim NK; Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.; Pokaż więcej
Źródło:: Cancers [Cancers (Basel)] 2022 Mar 12; Vol. 14 (6). Date of Electronic Publication: 2022 Mar 12.
Typ publikacji:: Journal Article

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 4.

Tytuł:: Influencers of the Decision to Undergo Contralateral Prophylactic Mastectomy among Women with Unilateral Breast Cancer.
Autorzy:: Singareeka Raghavendra A; Department of Breast Medical Oncology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
Alameddine HF; Kindred Hospital Department of Nursing, Sugar Land, TX 77479, USA.
Andersen CR; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
Selber JC; Department of Plastic Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
Brewster AM; Department of Breast Medical Oncology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
Barcenas CH; Department of Breast Medical Oncology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
Caudle AS; Department of Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
Arun BK; Department of Breast Medical Oncology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
Tripathy D; Department of Breast Medical Oncology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
Ibrahim NK; Department of Breast Medical Oncology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.; Pokaż więcej
Źródło:: Cancers [Cancers (Basel)] 2021 Apr 23; Vol. 13 (9). Date of Electronic Publication: 2021 Apr 23.
Typ publikacji:: Journal Article

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 5.

Tytuł:: EpCAM-independent isolation of circulating tumor cells with epithelial-to-mesenchymal transition and cancer stem cell phenotypes using ApoStream® in patients with breast cancer treated with primary systemic therapy.
Autorzy:: Le Du F; Department of Breast Medical Oncology, Section of Translational Breast Cancer Research, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America.; Department of Medical Oncology, Eugène Marquis Cancer Center, Rennes, France.
Fujii T; Department of Breast Medical Oncology, Section of Translational Breast Cancer Research, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America.
Kida K; Department of Breast Medical Oncology, Section of Translational Breast Cancer Research, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America.
Davis DW; ApoCell, Inc., Houston, Texas, United States of America.
Park M; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America.
Liu DD; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America.
Wu W; ApoCell, Inc., Houston, Texas, United States of America.
Chavez-MacGregor M; Department of Breast Medical Oncology, Section of Translational Breast Cancer Research, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America.
Barcenas CH; Department of Breast Medical Oncology, Section of Translational Breast Cancer Research, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America.
Valero V; Department of Breast Medical Oncology, Section of Translational Breast Cancer Research, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America.
Tripathy D; Department of Breast Medical Oncology, Section of Translational Breast Cancer Research, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America.
Reuben JM; Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America.
Ueno NT; Department of Breast Medical Oncology, Section of Translational Breast Cancer Research, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America.; Pokaż więcej
Źródło:: PloS one [PLoS One] 2020 Mar 26; Vol. 15 (3), pp. e0229903. Date of Electronic Publication: 2020 Mar 26 (Print Publication: 2020).
Typ publikacji:: Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:: Breast Neoplasms/*blood
Cadherins/*blood
Epithelial Cell Adhesion Molecule/*blood
Neoplastic Cells, Circulating/*metabolism
Adult ; Aged ; Antigens, Neoplasm/blood ; Biomarkers, Tumor/blood ; Breast Neoplasms/classification ; Breast Neoplasms/drug therapy ; Breast Neoplasms/pathology ; Cell Count ; Cell Line, Tumor ; Epithelial-Mesenchymal Transition/genetics ; Female ; Humans ; Middle Aged ; Neoadjuvant Therapy ; Neoplastic Stem Cells/metabolism ; Neoplastic Stem Cells/pathology ; Proto-Oncogene Proteins c-bcl-2/blood ; Vimentin/blood

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 6.

Tytuł:: Clinical characteristics of colitis induced by taxane-based chemotherapy.
Autorzy:: Chen E; Department of Medicine, Baylor College of Medicine (Ellie Chen, Niharika Mallepally).
Abu-Sbeih H; Department of Gastroenterology, Hepatology and Nutrition, The University of Texas MD Anderson Cancer Center (Hamzah Abu-Sbeih, Selvi Thirumurthi, Yinghong Wang).
Thirumurthi S; Department of Gastroenterology, Hepatology and Nutrition, The University of Texas MD Anderson Cancer Center (Hamzah Abu-Sbeih, Selvi Thirumurthi, Yinghong Wang).
Mallepally N; Department of Medicine, Baylor College of Medicine (Ellie Chen, Niharika Mallepally).
Khurana S; Department of Internal Medicine, McGovern Medical School, The University of Texas Health Science Center (Shruti Khurana).
Wei D; Department of Pathology and Lab Medicine, The University of Texas MD Anderson Cancer Center (Dongguang Wei, Dongfeng Tan).
Altan M; Department of Thoracic/Head and Neck Medical Oncology, The University of Texas MD Anderson, Cancer Center (Mehmet Altan).
Morris VK; Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center (Van K. Morris).
Tan D; Department of Pathology and Lab Medicine, The University of Texas MD Anderson Cancer Center (Dongguang Wei, Dongfeng Tan).
Barcenas CH; Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center (Carlos H. Barcenas), Houston, Texas, USA.
Wang Y; Department of Gastroenterology, Hepatology and Nutrition, The University of Texas MD Anderson Cancer Center (Hamzah Abu-Sbeih, Selvi Thirumurthi, Yinghong Wang).; Pokaż więcej
Źródło:: Annals of gastroenterology [Ann Gastroenterol] 2020 Jan-Feb; Vol. 33 (1), pp. 59-67. Date of Electronic Publication: 2019 Nov 21.
Typ publikacji:: Journal Article

Czasopismo naukowe

na półce

Pełny tekst Szczegóły

Skocz do pozycji: 7.

Tytuł:: Patients with breast cancer may be at higher risk of colorectal neoplasia.
Autorzy:: Abu-Sbeih H; Department of Gastroenterology, Hepatology, and Nutrition, The University of Texas MD Anderson Cancer Center, Houston, Texas (Hamzah Abu-Sbeih, Phillip S. Ge, Phillip Lum, Robert S. Bresalier, Manoop S. Bhutani, Gottumukkala S. Raju, Yinghong Wang).
Ali FS; Department of Internal Medicine, Presence Saint Joseph Hospital, Chicago, IL (Faisal S. Ali).
Ge PS; Department of Gastroenterology, Hepatology, and Nutrition, The University of Texas MD Anderson Cancer Center, Houston, Texas (Hamzah Abu-Sbeih, Phillip S. Ge, Phillip Lum, Robert S. Bresalier, Manoop S. Bhutani, Gottumukkala S. Raju, Yinghong Wang).
Barcenas CH; Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas (Carlos H. Barcenas).
Lum P; Department of Gastroenterology, Hepatology, and Nutrition, The University of Texas MD Anderson Cancer Center, Houston, Texas (Hamzah Abu-Sbeih, Phillip S. Ge, Phillip Lum, Robert S. Bresalier, Manoop S. Bhutani, Gottumukkala S. Raju, Yinghong Wang).
Qiao W; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, Texas (Wei Qiao), USA.
Bresalier RS; Department of Gastroenterology, Hepatology, and Nutrition, The University of Texas MD Anderson Cancer Center, Houston, Texas (Hamzah Abu-Sbeih, Phillip S. Ge, Phillip Lum, Robert S. Bresalier, Manoop S. Bhutani, Gottumukkala S. Raju, Yinghong Wang).
Bhutani MS; Department of Gastroenterology, Hepatology, and Nutrition, The University of Texas MD Anderson Cancer Center, Houston, Texas (Hamzah Abu-Sbeih, Phillip S. Ge, Phillip Lum, Robert S. Bresalier, Manoop S. Bhutani, Gottumukkala S. Raju, Yinghong Wang).
Raju GS; Department of Gastroenterology, Hepatology, and Nutrition, The University of Texas MD Anderson Cancer Center, Houston, Texas (Hamzah Abu-Sbeih, Phillip S. Ge, Phillip Lum, Robert S. Bresalier, Manoop S. Bhutani, Gottumukkala S. Raju, Yinghong Wang).
Wang Y; Department of Gastroenterology, Hepatology, and Nutrition, The University of Texas MD Anderson Cancer Center, Houston, Texas (Hamzah Abu-Sbeih, Phillip S. Ge, Phillip Lum, Robert S. Bresalier, Manoop S. Bhutani, Gottumukkala S. Raju, Yinghong Wang).; Pokaż więcej
Źródło:: Annals of gastroenterology [Ann Gastroenterol] 2019 Jul-Aug; Vol. 32 (4), pp. 400-406. Date of Electronic Publication: 2019 May 20.
Typ publikacji:: Journal Article

Czasopismo naukowe

na półce

Pełny tekst Szczegóły

Skocz do pozycji: 8.

Tytuł:: Androgen receptor expression on circulating tumor cells in metastatic breast cancer.
Autorzy:: Fujii T; Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America.
Reuben JM; Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America.
Huo L; Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America.
Espinosa Fernandez JR; Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America.
Gong Y; Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America.
Krupa R; Department of Translational Research, Epic Sciences, La Jolla, California, United States of America.
Suraneni MV; Department of Translational Research, Epic Sciences, La Jolla, California, United States of America.
Graf RP; Department of Translational Research, Epic Sciences, La Jolla, California, United States of America.
Lee J; Department of Translational Research, Epic Sciences, La Jolla, California, United States of America.
Greene S; Department of Translational Research, Epic Sciences, La Jolla, California, United States of America.
Rodriguez A; Department of Translational Research, Epic Sciences, La Jolla, California, United States of America.
Dugan L; Department of Translational Research, Epic Sciences, La Jolla, California, United States of America.
Louw J; Department of Translational Research, Epic Sciences, La Jolla, California, United States of America.
Lim B; Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America.
Barcenas CH; Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America.
Marx AN; Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America.
Tripathy D; Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America.
Wang Y; Department of Translational Research, Epic Sciences, La Jolla, California, United States of America.
Landers M; Department of Translational Research, Epic Sciences, La Jolla, California, United States of America.
Dittamore R; Department of Translational Research, Epic Sciences, La Jolla, California, United States of America.
Ueno NT; Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America.; Pokaż więcej
Źródło:: PloS one [PLoS One] 2017 Sep 28; Vol. 12 (9), pp. e0185231. Date of Electronic Publication: 2017 Sep 28 (Print Publication: 2017).
Typ publikacji:: Journal Article
MeSH Terms:: Breast Neoplasms/*metabolism
Breast Neoplasms/*pathology
Neoplastic Cells, Circulating/*metabolism
Neoplastic Cells, Circulating/*pathology
Receptors, Androgen/*metabolism
Adult ; Aged ; Breast Neoplasms/genetics ; DNA Copy Number Variations/genetics ; Female ; Humans ; Immunohistochemistry ; Middle Aged ; Neoplasm Metastasis ; Prevalence ; Receptor, ErbB-2/metabolism ; Receptors, Estrogen/metabolism ; Single-Cell Analysis

Czasopismo naukowe

na półce

Pełny tekst Szczegóły

Skocz do pozycji: 9.

Tytuł:: Location of Receipt of Initial Treatment and Outcomes in Long-Term Breast Cancer Survivors.
Autorzy:: Sinha AK; Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America.; Department of Biostatistics, The University of Texas School of Public Health, Houston, Texas, United States of America.
Patel JR; Division of Epidemiology, Human Genetics and Environmental Sciences, The University of Texas School of Public Health, Houston, Texas, United States of America.
Shen Y; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America.
Ueno NT; Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America.
Giordano SH; Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America.; Department of Health Services Research, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America.
Tripathy D; Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America.
Lopez DS; Division of Epidemiology, Human Genetics and Environmental Sciences, The University of Texas School of Public Health, Houston, Texas, United States of America.
Barcenas CH; Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America.; Pokaż więcej
Źródło:: PloS one [PLoS One] 2017 Jan 13; Vol. 12 (1), pp. e0170081. Date of Electronic Publication: 2017 Jan 13 (Print Publication: 2017).
Typ publikacji:: Journal Article
MeSH Terms:: Breast Neoplasms/*mortality
Carcinoma, Ductal, Breast/*mortality
Carcinoma, Lobular/*mortality
Health Services/*statistics & numerical data
Neoplasm Recurrence, Local/*mortality
Quality of Health Care/*organization & administration
Adult ; Biomarkers, Tumor/metabolism ; Breast Neoplasms/pathology ; Breast Neoplasms/therapy ; Carcinoma, Ductal, Breast/pathology ; Carcinoma, Ductal, Breast/therapy ; Carcinoma, Lobular/pathology ; Carcinoma, Lobular/therapy ; Combined Modality Therapy ; Female ; Humans ; Middle Aged ; Neoplasm Grading ; Neoplasm Invasiveness ; Neoplasm Recurrence, Local/pathology ; Neoplasm Recurrence, Local/therapy ; Neoplasm Staging ; Prognosis ; Receptor, ErbB-2/metabolism ; Receptors, Estrogen/metabolism ; Receptors, Progesterone/metabolism ; Retrospective Studies ; Survival Rate